Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 32 entries
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adherens junction 💬 9 genes, 19 drugs (DrugBank) and 23 diseases |
FGFR1 [1] FGFR1 💬Adherens junction
|
Infigratinib Infigratinib 💬Adherens junction
| Infigratinib | 276 [1] 276 💬1. Adherens junction
|
||||||||||||||||||||||
| 2 | Adherens junction 💬 9 genes, 19 drugs (DrugBank) and 23 diseases |
FGFR1 [1] FGFR1 💬Adherens junction
|
Nintedanib Nintedanib 💬Adherens junction
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
||||||||||||||||||||||
| 3 | Breast cancer 💬 21 genes, 60 drugs (DrugBank) and 74 diseases |
FGFR1 [1] FGFR1 💬Breast cancer
|
Infigratinib Infigratinib 💬Breast cancer
| Infigratinib | 276 [1] 276 💬3. Breast cancer
|
||||||||||||||||||||||
| 4 | Breast cancer 💬 21 genes, 60 drugs (DrugBank) and 74 diseases |
FGFR1 [2] FGFR1, FLT4 💬
|
Nintedanib Nintedanib 💬Breast cancer
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
||||||||||||||||||||||
| 5 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
FGFR1 [3] FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬Calcium signaling pathway
| Infigratinib | 276 [1] 276 💬5. Calcium signaling pathway
|
||||||||||||||||||||||
| 6 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
FGFR1 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬Calcium signaling pathway
|
Nintedanib Nintedanib 💬Calcium signaling pathway
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
||||||||||||||||||||||
| 7 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
FGFR1 [3] FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬Central carbon metabolism in cancer
| Infigratinib | 276 [1] 276 💬7. Central carbon metabolism in cancer
|
||||||||||||||||||||||
| 8 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
FGFR1 [5] FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬
|
Nintedanib Nintedanib 💬Central carbon metabolism in cancer
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|
||||||||||||||||||||||
| 9 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
FGFR1 [3] FGFR1, FGFR2, FGFR3 💬
|
Infigratinib Infigratinib 💬MAPK signaling pathway
| Infigratinib | 276 [1] 276 💬9. MAPK signaling pathway
|
||||||||||||||||||||||
| 10 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
FGFR1 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬MAPK signaling pathway
|
Nintedanib Nintedanib 💬MAPK signaling pathway
| Nintedanib | 051 [5] 51, 85, 89, 227, 228 💬
|